Walgreens Boots Alliance earnings topped $1 billion during the fourth quarter, easily surpassing analyst expectations, but also announced a delay in closing its latest megadeal.
Walgreens Boots says it will probably have to unload more stores than expected to ease antitrust concerns over its pending acquisition of Rite Aid, a deal that would make the nation's largest drugstore chain even larger.
The not-for-profit Catholic organization SSM Health will provide birth control pills at the 26 clinics inside St. Louis-area Walgreens stores that it began operating Thursday, an SSM spokesman said.
Activist investors in for-profit healthcare firms want seasoned leaders—often drawn from the ranks of former leaders of not-for-profit healthcare systems—to sit on their boards and help those firms navigate today's fast-changing reimbursement environment.
Troubled blood-testing startup Theranos says it will continue serving customers through independent retail locations a day after the nation's largest drugstore chain severed ties with the company.
Corporate CEOs, attorneys, real estate moguls and other business leaders routinely serve on the boards of not-for-profit hospitals, systems and insurers. But some top executives at not-for-profit healthcare organizations also hold board seats at some of the largest publicly traded companies in the...
Ponder the fleeting nature of fortune. Last fall, Theranos CEO Elizabeth Holmes, 32, was deemed the “youngest self-made female billionaire” in the world by Forbes magazine. Her net worth today? Bupkis.
Drugstore giant Walgreens Boots Alliance has taken another step in its effort to be viewed as a healthcare provider alternative. Walgreens is collaborating with the behavioral health advocacy group Mental Health America to provide mental health screening to as many as 3 million people through 2017.
Walgreens will pay $500,000 to settle the latest case of a company accused of duping New York consumers over prices.
Walgreens beat Wall Street's earnings expectations for its fiscal second quarter as sales rose nearly 14%, but the nation's largest drugstore chain remained conservative with its outlook for the year.
Slumping stock prices and the quickening pace of change in how providers get paid are testing boards of directors at publicly traded healthcare firms in ways they haven't seen in a generation.
The U.S. Food and Drug Administration approved a new hepatitis C pill developed by Merck & Co. The combination pill Zepatier includes the medications elbasvir and grazoprevir, which attack the liver-destroying virus in two ways.